Aclaris Therapeutics Inc (ACRS)
1.17
-0.05
(-4.10%)
USD |
NASDAQ |
Apr 24, 16:00
1.18
+0.01
(+0.85%)
After-Hours: 20:00
Aclaris Therapeutics Total Liabilities (Quarterly): 40.23M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 40.23M |
September 30, 2023 | 62.02M |
June 30, 2023 | 55.90M |
March 31, 2023 | 52.90M |
December 31, 2022 | 56.98M |
September 30, 2022 | 47.79M |
June 30, 2022 | 42.22M |
March 31, 2022 | 46.33M |
December 31, 2021 | 53.87M |
September 30, 2021 | 46.91M |
June 30, 2021 | 54.23M |
March 31, 2021 | 49.10M |
December 31, 2020 | 33.13M |
September 30, 2020 | 31.14M |
June 30, 2020 | 35.63M |
March 31, 2020 | 38.64M |
December 31, 2019 | 28.38M |
September 30, 2019 | 75.14M |
Date | Value |
---|---|
June 30, 2019 | 80.01M |
March 31, 2019 | 70.93M |
December 31, 2018 | 60.44M |
September 30, 2018 | 29.85M |
June 30, 2018 | 27.62M |
March 31, 2018 | 20.15M |
December 31, 2017 | 18.25M |
September 30, 2017 | 17.13M |
June 30, 2017 | 8.664M |
March 31, 2017 | 5.921M |
December 31, 2016 | 6.595M |
September 30, 2016 | 4.949M |
June 30, 2016 | 5.852M |
March 31, 2016 | 4.059M |
December 31, 2015 | 1.555M |
September 30, 2015 | 80.20M |
June 30, 2015 | 1.427M |
December 31, 2014 | 38.13M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
28.38M
Minimum
Dec 2019
80.01M
Maximum
Jun 2019
48.98M
Average
47.79M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
Aldeyra Therapeutics Inc | 28.53M |
Akoya Biosciences Inc | 126.60M |
MSP Recovery Inc | 1.741B |
Bullfrog AI Holdings Inc | 0.1844M |
Cadrenal Therapeutics Inc | 0.8269M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 197.40M |
Shareholders Equity (Quarterly) | 157.18M |
Current Ratio | 4.163 |